| [1] |
|
| [2] |
MASAKI Y, DONG L, KUROSE N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders[J]. Ann Rheum Dis, 2009, 68(8): 1310-1315. DOI: 10.1136/ard.2008.089169. |
| [3] |
DESHPANDE V, ZEN Y, CHAN JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192. DOI: 10.1038/modpathol.2012.72. |
| [4] |
KHOSROSHAHI A, WALLACE ZS, CROWE JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699. DOI: 10.1002/art.39132. |
| [5] |
STONE JH, KHOSROSHAHI A, DESHPANDE V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations[J]. Arthritis Rheum, 2012, 64(10): 3061-3067. DOI: 10.1002/art.34593. |
| [6] |
LI W, CHEN Y, SUN Z P, et al. Clinicopathological characteristics of immunoglobulin G4-related sialadenitis[J]. Arthritis Res Ther, 2015, 17(1): 186. DOI: 10.1186/s13075-015-0698-y. |
| [7] |
LIU Y, XUE M, WANG Z, et al. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients[J]. Rheumatology (Oxford), 2020, 59(3): 634-640. DOI: 10.1093/rheumatology/kez280. |
| [8] |
Editorial board of Chinese Journal of pancreatic diseases. Chinese consus on autoimune pancreatitis (Draft 2012, Shanghai)[J]. Chin J Pancreatol, 2012, 12(6): 410-418. DOI: 10.3760/cma.j.issn.1674-1935.2012.06.017. |
| [9] |
CAI O, TAN S. From pathogenesis, clinical manifestation, and diagnosis to treatment: an overview on autoimmune pancreatitis[J]. Gastroenterol Res Pract, 2017, 2017: 3246459. DOI: 10.1155/2017/3246459. |
| [10] |
MARUYAMA M, WATANABE T, KANAI K, et al. International consensus diagnostic criteria for autoimmune pancreatitis and its Japanese amendment have improved diagnostic ability over existing criteria[J]. Gastroenterol Res Pract, 2013, 2013: 456965. DOI: 10.1155/2013/456965. |
| [11] |
LUO Y, PAN Q, YANG H, et al. Fibroblast activation protein-targeted PET/CT with 68Ga-FAPI for imaging IgG4-related disease: Comparison to 18F-FDG PET/CT[J]. J Nucl Med, 2021, 62(2): 266-271. DOI: 10.2967/jnumed.120.244723. |
| [12] |
SAHANI DV, KALVA SP, FARRELL J, et al. Autoimmune pancreatitis: imaging features[J]. Radiology, 2004, 233(2): 345-352. DOI: 10.1148/radiol.2332031436. |
| [13] |
MIZUSHIMA I, KASASHIMA S, FUJINAGA Y, et al. IgG4-related periaortitis/periarteritis: An under-recognized condition that is potentially life-threatening[J]. Mod Rheumatol, 2019, 29(2): 240-250. DOI: 10.1080/14397595.2018.1546367. |
| [14] |
ZHANG J, CHEN H, MA Y, et al. Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study[J]. Eur J Nucl Med Mol Imaging, 2014, 41(8): 1624-1634. DOI: 10.1007/s00259-014-2729-3. |
| [15] |
VLACHOU PA, KHALILI K, JANG HJ, et al. IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations[J]. Radiographics, 2011, 31(5): 1379-1402. DOI: 10.1148/rg.315105735. |
| [16] |
INOUE D, YOSHIDA K, YONEDA N, et al. IgG4-related disease: dataset of 235 consecutive patients[J]. Medicine (Baltimore), 2015, 94(15): e680. DOI: 10.1097/MD.0000000000000680. |
| [17] |
PENG L, ZHANG P, LI J, et al. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease[J]. Arthritis Res Ther, 2020, 22(1): 103. DOI: 10.1186/s13075-020-02197-w. |
| [18] |
PERUGINO CA, WALLACE ZS, MEYERSOHN N, et al. Large vessel involvement by IgG4-related disease[J]. Medicine (Baltimore), 2016, 95(28): e3344. DOI: 10.1097/MD.0000000000003344. |
| [19] |
INOUE D, ZEN Y, ABO H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients[J]. Radiology, 2011, 261(2): 625-633. DOI: 10.1148/radiol.11102250. |
| [20] |
KANNO A, NISHIMORI I, MASAMUNE A, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan[J]. Pancreas, 2012, 41(6): 835-839. DOI: 10.1097/MPA.0b013e3182480c99. |
| [21] |
|
| [22] |
LIN W, LU S, CHEN H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients[J]. Rheumatology (Oxford), 2015, 54(11): 1982-1990. DOI: 10.1093/rheumatology/kev203. |
| [23] |
WANG K, WANG Z, ZENG Q, et al. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis[J]. PLoS One, 2021, 16(2): e0245601. DOI: 10.1371/journal.pone.0245601. |
| [24] |
PERUGINO CA, WALLACE ZS, MEYERSOHN N, et al. Large vessel involvement by IgG4-related disease[J]. Medicine (Baltimore), 2016, 95(28): e3344. DOI: 10.1097/MD.0000000000003344. |
DownLoad:
